197 related articles for article (PubMed ID: 16382049)
1. External imaging of CCND1, MYC, and KRAS oncogene mRNAs with tumor-targeted radionuclide-PNA-peptide chimeras.
Tian X; Chakrabarti A; Amirkhanov NV; Aruva MR; Zhang K; Mathew B; Cardi C; Qin W; Sauter ER; Thakur ML; Wickstrom E
Ann N Y Acad Sci; 2005 Nov; 1059():106-44. PubMed ID: 16382049
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive molecular imaging of MYC mRNA expression in human breast cancer xenografts with a [99mTc]peptide-peptide nucleic acid-peptide chimera.
Tian X; Aruva MR; Qin W; Zhu W; Sauter ER; Thakur ML; Wickstrom E
Bioconjug Chem; 2005; 16(1):70-9. PubMed ID: 15656577
[TBL] [Abstract][Full Text] [Related]
3. External imaging of CCND1 cancer gene activity in experimental human breast cancer xenografts with 99mTc-peptide-peptide nucleic acid-peptide chimeras.
Tian X; Aruva MR; Qin W; Zhu W; Duffy KT; Sauter ER; Thakur ML; Wickstrom E
J Nucl Med; 2004 Dec; 45(12):2070-82. PubMed ID: 15585484
[TBL] [Abstract][Full Text] [Related]
4. PET imaging of CCND1 mRNA in human MCF7 estrogen receptor positive breast cancer xenografts with oncogene-specific [64Cu]chelator-peptide nucleic acid-IGF1 analog radiohybridization probes.
Tian X; Aruva MR; Zhang K; Shanthly N; Cardi CA; Thakur ML; Wickstrom E
J Nucl Med; 2007 Oct; 48(10):1699-707. PubMed ID: 17909257
[TBL] [Abstract][Full Text] [Related]
5. Radiohybridization PET imaging of KRAS G12D mRNA expression in human pancreas cancer xenografts with [(64)Cu]DO3A-peptide nucleic acid-peptide nanoparticles.
Chakrabarti A; Zhang K; Aruva MR; Cardi CA; Opitz AW; Wagner NJ; Thakur ML; Wickstrom E
Cancer Biol Ther; 2007 Jun; 6(6):948-56. PubMed ID: 17611392
[TBL] [Abstract][Full Text] [Related]
6. Receptor-mediated internalization of chelator-PNA-peptide hybridization probes for radioimaging or magnetic resonance imaging of oncogene mRNAs in tumours.
Tian X; Chakrabarti A; Amirkhanov N; Aruva MR; Zhang K; Cardi CA; Lai S; Thakur ML; Wickstrom E
Biochem Soc Trans; 2007 Feb; 35(Pt 1):72-6. PubMed ID: 17233604
[TBL] [Abstract][Full Text] [Related]
7. Imaging human pancreatic cancer xenografts by targeting mutant KRAS2 mRNA with [(111)In]DOTA(n)-poly(diamidopropanoyl)(m)-KRAS2 PNA-D(Cys-Ser-Lys-Cys) nanoparticles.
Amirkhanov NV; Zhang K; Aruva MR; Thakur ML; Wickstrom E
Bioconjug Chem; 2010 Apr; 21(4):731-40. PubMed ID: 20232877
[TBL] [Abstract][Full Text] [Related]
8. Imaging oncogene expression.
Tian X; Aruva MR; Rao PS; Qin W; Read P; Sauter ER; Thakur ML; Wickstrom E
Ann N Y Acad Sci; 2003 Dec; 1002():165-88. PubMed ID: 14751834
[TBL] [Abstract][Full Text] [Related]
9. Preparation and Evaluation of (99m)Tc-Epidermal Growth Factor Receptor (EGFR)-Peptide Nucleic Acid for Visualization of EGFR Messenger RNA Expression in Malignant Tumors.
Zhao X; Wang N; Ren X; Zhang J; Wang J; Han J; Jia L; Liu Y; Zhang Z
J Nucl Med; 2014 Jun; 55(6):1008-16. PubMed ID: 24744447
[TBL] [Abstract][Full Text] [Related]
10. Tumor-targeting peptide-PNA-peptide chimeras for imaging overexpressed oncogene mRNAs.
Tian X; Aruva MR; Wolfe HR; Qin W; Sauter ER; Thakur ML; Waldman SA; Wickstrom E
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):1085-91. PubMed ID: 16248097
[TBL] [Abstract][Full Text] [Related]
11. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
[TBL] [Abstract][Full Text] [Related]
12. Transcription inhibition of oncogenic KRAS by a mutation-selective peptide nucleic acid conjugated to the PKKKRKV nuclear localization signal peptide.
Cogoi S; Codognotto A; Rapozzi V; Meeuwenoord N; van der Marel G; Xodo LE
Biochemistry; 2005 Aug; 44(31):10510-9. PubMed ID: 16060660
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-peptide-peptide nucleic acid probes for imaging oncogene mRNAs in tumours.
Rao PS; Tian X; Qin W; Aruva MR; Sauter ER; Thakur ML; Wickstrom E
Nucl Med Commun; 2003 Aug; 24(8):857-63. PubMed ID: 12869817
[TBL] [Abstract][Full Text] [Related]
15. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.
Dadiani M; Seger D; Kreizman T; Badikhi D; Margalit R; Eilam R; Degani H
Endocr Relat Cancer; 2009 Sep; 16(3):819-34. PubMed ID: 19398483
[TBL] [Abstract][Full Text] [Related]
16. Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression.
Yang C; Trent S; Ionescu-Tiba V; Lan L; Shioda T; Sgroi D; Schmidt EV
Cancer Res; 2006 Dec; 66(24):11649-58. PubMed ID: 17178859
[TBL] [Abstract][Full Text] [Related]
17. PEG10 is a c-MYC target gene in cancer cells.
Li CM; Margolin AA; Salas M; Memeo L; Mansukhani M; Hibshoosh H; Szabolcs M; Klinakis A; Tycko B
Cancer Res; 2006 Jan; 66(2):665-72. PubMed ID: 16423995
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
